Prevalence of Helicobacter hepaticus, murine norovirus, and Pneumocystis carinii and eradication efficacy of cross-fostering in genetically engineered mice

Experimental Animals

Volumn 58, Issue 5, 2009, Pages 497-504

  Yeom, Su Cheong ^a   Yu, Sun A ^a   Choi, Eun Young ^a   Lee, Byeong Chun ^a   Lee, Wang Jae ^a  

^a Seoul National University   (South Korea)

Author keywords

Cross fostering; Helicobacter hepaticus; Murine norovirus; Pneumocystis carinii; Prevalence

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL IMMUNITY; CONTROLLED STUDY; FEMALE; HELICOBACTER HEPATICUS; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; INFECTION RESISTANCE; INFECTION SENSITIVITY; MALE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; NOROVIRUS; PNEUMOCYSTIS CARINII; PREVALENCE; STRAIN DIFFERENCE; TRANSGENIC MOUSE; VIRUS IMMUNITY;

ANIMAL HUSBANDRY; ANIMALS; ANIMALS, SUCKLING; CALICIVIRIDAE INFECTIONS; DISEASE TRANSMISSION, INFECTIOUS; HELICOBACTER INFECTIONS; MICE; MICE, TRANSGENIC; MOLECULAR EPIDEMIOLOGY; PNEUMOCYSTIS INFECTIONS; POLYMERASE CHAIN REACTION; RODENT DISEASES; SPECIES SPECIFICITY;

HELICOBACTER HEPATICUS; MURINE NOROVIRUS; MUS; PNEUMOCYSTIS CARINII;

EID: 73249140136     PISSN: 13411357     EISSN: None     Source Type: Journal    
DOI: 10.1538/expanim.58.497     Document Type: Article

References (35)

1. An, C.L., Gigliotti, F., and Harmsen, A.G. 2003. Exposure of immunocompetent adult mice to Pneumocystis carinii f. sp. muris by cohousing: growth of P. carinii f. sp. muris and host immune response. Infect. Immun. 71: 2065-2070.
2. Beck, J.M., Warnock, M.L., Curtis, J.L., Sniezek, M.J., Arraj-Peffer, S.M., Kaltreider, H.B., and Shellito, J.E. 1991. Inflammatory responses to Pneumocystis carinii in mice selectively depleted of helper T lymphocytes. Am. J. Respir. Cell Mol. Biol. 5: 186-197.
3. Bohr, U.R., Selgrad, M., Ochmann, C., Backert, S., Konig, W., Fenske, A., Wex, T., and Malfertheiner, P. 2006. Prevalence and spread of enterohepatic Helicobacter species in mice reared in a specific-pathogen-free animal facility. J. Clin. Microbiol. 44: 738-742.
4. Compton, S.R. 2008. Prevention of murine norovirus infection in neonatal mice by fostering. J. Am. Assoc. Lab. Anim. Sci. 47: 25-30.
5. Crisler-Roberts, R., Ge, Z., Kearney, M.T., Singletary, K.B., Fox, J.G., Roberts, C.S., and Baker, D.G. 2005. Evaluation of Helicobacter hepaticus bacterial shedding in fostered and sex-segregated C57BL/6 mice. Comp. Med. 55: 515-522.
6. Engle, S.J., Ormsby, I., Pawlowski, S., Boivin, G.P., Croft, J., Balish, E., and Doetschman, T. 2002. Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice. Cancer Res. 62: 6362-6366.
7. Foltz, C.J., Fox, J.G., Cahill, R., Murphy, J.C., Yan, L., Shames, B., and Schauer, D.B. 1998. Spontaneous inflammatory bowel disease in multiple mutant mouse lines: association with colonization by Helicobacter hepaticus. Helicobacter 3: 69-78.
8. Franklin, C.L. 2006. Microbial considerations in genetically engineered mouse research. ILAR J. 47: 141-155.
9. Furuta, T., Nagata, T., Kikuchi, T., and Kikutani, H. 2001. Fatal spontaneous pneumocystosis in CD40 knockout mice. J. Eukaryot. Microbiol. Suppl: 129S-130S.
10. Goto, K., Ohashi, H., Takakura, A., and Itoh, T. 2000. Current status of Helicobacter contamination of laboratory mice, rats, gerbils, and house musk shrews in Japan. Curr. Microbiol. 41: 161-166.
11. Guo, L., Wang, J., Zhou, H., Si, H., Wang, M., Song, J., Han, B., Shu, Y., Ren, L., Qu, J., and Hung, T. 2008. Intranasal administration of a recombinant adenovirus expressing the norovirus capsid protein stimulates specific humoral, mucosal, and cellular immune responses in mice. Vaccine 26: 460-468.
12. Henderson, K.S. 2008. Murine norovirus, a recently discovered and highly prevalent viral agent of mice. Lab. Anim. (NY) 37: 314-320.
13. Karst, S.M., Wobus, C.E., Lay, M., Davidson, J., and Virgin, H.W.T. 2003. STAT1-dependent innate immunity to a Norwalk-like virus. Science 299: 1575-1578.
14. Kerton, A. and Warden, P. 2006. Review of successful treatment for Helicobacter species in laboratory mice. Lab. Anim. 40: 115-122.
15. Kostomitsopoulos, N., Donnelly, H., Kostavasili, I., Paronis, E., Alexakos, P., and Karayannacos, P. 2007. Eradication of Helicobacter bilis and H. hepaticus from infected mice by using a medicated diet. Lab. Anim. (NY) 36: 37-40.
16. Kullberg, M.C., Ward, J.M., Gorelick, P.L., Caspar, P., Hieny, S., Cheever, A., Jankovic, D., and Sher, A. 1998. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect. Immun. 66: 5157-5166.
17. Lencioni, K.C., Seamons, A., Treuting, P.M., Maggio-Price, L., and Brabb, T. 2008. Murine norovirus: an intercurrent variable in a mouse model of bacteria-induced inflammatory bowel disease. Comp. Med. 58: 522-533.
18. Li, X., Fox, J.G., Whary, M.T., Yan, L., Shames, B., and Zhao, Z. 1998. SCID/NCr mice naturally infected with Helicobacter hepaticus develop progressive hepatitis, proliferative typhlitis, and colitis. Infect. Immun. 66: 5477-5484.
19. Livingston, R.S., Myles, M.H., Livingston, B.A., Criley, J.M., and Franklin, C.L. 2004. Sex influence on chronic intestinal inflammation in Helicobacter hepaticus-infected A/JCr mice. Comp. Med. 54: 301-308.
20. Macy, J.D. Jr., Weir, E.C., Compton, S.R., Shlomchik, M.J., and Brownstein, D.G. 2000. Dual infection with Pneumocystis carinii and Pasteurella pneumotropica in B cell-deficient mice: diagnosis and therapy. Comp. Med. 50: 49-55.
21. Maurer, K.J., Ihrig, M.M., Rogers, A.B., Ng, V., Bouchard, G., Leonard, M.R., Carey, M.C., and Fox, J.G. 2005. Identification of cholelithogenic enterohepatic helicobacter species and their role in murine cholesterol gallstone formation. Gastroenterology 128: 1023-1033.
22. Mumphrey, S.M., Changotra, H., Moore, T.N., Heimann-Nichols, E.R., Wobus, C.E., Reilly, M.J., Moghadamfalahi, M., Shukla, D., and Karst, S.M. 2007. Murine norovirus 1 infection is associated with histopathological changes in immunocompetent hosts, but clinical disease is prevented by STAT1-dependent interferon responses. J. Virol. 81: 3251-3263.
23. Myles, M.H., Livingston, R.S., Livingston, B.A., Criley, J.M., and Franklin, C.L. 2003. Analysis of gene expression in ceca of Helicobacter hepaticus-infected A/JCr mice before and after development of typhlitis. Infect. Immun. 71: 3885-3893.
24. Nagamine, C.M., Sohn, J.J., Rickman, B.H., Rogers, A.B., Fox, J.G., and Schauer, D.B. 2008. Helicobacter hepaticus infection promotes colon tumorigenesis in the BALB/c-Rag2(-/-) Apc(Min/+) mouse. Infect. Immun. 76: 2758-2766.
25. Roths, J.B., Marshall, J.D., Allen, R.D., Carlson, G.A., and Sidman, C.L. 1990. Spontaneous Pneumocystis carinii pneumonia in immunodeficient mutant scid mice. Natural history and pathobiology. Am. J. Pathol. 136: 1173-1186.
26. Seok, S., Park, J., Cho, S., Baek, M., Lee, H., Kim, D., Yang, K., Jang, D., Han, B., and Nam, K. 2005. Health surveillance of specific pathogen-free and conventionally-housed mice and rats in Korea. Exp. Anim. 54: 85-92.
27. Shames, B., Fox, J.G., Dewhirst, F., Yan, L., Shen, Z., and Taylor, N.S. 1995. Identification of widespread Helicobacter hepaticus infection in feces in commercial mouse colonies by culture and PCR assay. J. Clin. Microbiol. 33: 2968-2972.
28. Singletary, K.B., Kloster, C.A., and Baker, D.G. 2003. Optimal age at fostering for derivation of Helicobacter hepaticus-free mice. Comp. Med. 53: 259-264.
29. Truett, G.E., Walker, J.A., and Baker, D.G. 2000. Eradication of infection with Helicobacter spp. by use of neonatal transfer. Comp. Med. 50: 444-451.
30. Van Keuren, M.L. and Saunders, T.L. 2004. Rederivation of transgenic and gene-targeted mice by embryo transfer. Transgenic Res. 13: 363-371.
31. Ward, J.M., Fox, J.G., Anver, M.R., Haines, D.C., George, C.V., Collins, M.J. Jr., Gorelick, P.L., Nagashima, K., Gonda, M.A., Gilden, R.V., Tully, J.G., Russell, R.J., Benvensite, R.E., Paster, B.J., Dewhirst, F.E., Donovan, J.C., Anderson, L.M., and Rice, J.M. 1994. Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J. Natl. Cancer. Inst. 86: 1222-1227.
32. Ward, J.M., Wobus, C.E., Thackray, L.B., Erexson, C.R., Faucette, L.J., Belliot, G., Barron, E.L., Sosnovtsev, S.V., and Green, K.Y. 2006. Pathology of immunodeficient mice with naturally occurring murine norovirus infection. Toxicol. Pathol. 34: 708-715.
33. Watson, J., Thompson, K.N., and Feldman, S.H. 2005. Successful rederivation of contaminated immunocompetent mice using neonatal transfer with iodine immersion. Comp. Med. 55: 465-469.
34. Whary, M.T., Cline, J.H., King, A.E., Hewes, K.M., Chojnacky, D., Salvarrey, A., and Fox, J.G. 2000. Monitoring sentinel mice for Helicobacter hepaticus, H rodentium, and H bilis infection by use of polymerase chain reaction analysis and serologic testing. Comp. Med. 50: 436-443.
35. Whary, M.T., Morgan, T.J., Dangler, C.A., Gaudes, K.J., Taylor, N.S., and Fox, J.G. 1998. Chronic active hepatitis induced by Helicobacter hepaticus in the A/JCr mouse is associated with a Th1 cell-mediated immune response. Infect. Immun. 66: 3142-3148.